These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 3024197
21. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H. Ho BY, Takemori AE. J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935 [Abstract] [Full Text] [Related]
22. Naloxone benzoylhydrazone, a kappa 3 opioid agonist, stimulates food intake in rats. Koch JE, Pasternak GW, Arjune D, Bodnar RJ. Brain Res; 1992 May 29; 581(2):311-4. PubMed ID: 1327401 [Abstract] [Full Text] [Related]
23. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade. Pugsley MK, Penz WP, Walker MJ, Wong TM. Br J Pharmacol; 1992 Mar 29; 105(3):521-6. PubMed ID: 1320979 [Abstract] [Full Text] [Related]
24. Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50-488H, microinjected into the ventral tegmental area in rats. Nencini P, Stewart J. Brain Res; 1990 Sep 17; 527(2):254-8. PubMed ID: 2174718 [Abstract] [Full Text] [Related]
25. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H. Bot G, Chahl LA, Brent PJ, Johnston PA. Neuropharmacology; 1992 Sep 17; 31(9):825-33. PubMed ID: 1359440 [Abstract] [Full Text] [Related]
26. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression. Castillo R, Kissin I, Bradley EL. Anesth Analg; 1986 Apr 17; 65(4):350-4. PubMed ID: 3006552 [Abstract] [Full Text] [Related]
27. Effect of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidin) cyclohexyl]-benzeneacetamide (U-50,488H), a kappa opioid receptor agonist, on intake of food in food-deprived and non-deprived spontaneously hypertensive and normotensive Wistar-Kyoto rats. Bhargava HN, Ramarao P, Richter CM, Bieniarz AA. Neuropharmacology; 1989 Jan 17; 28(1):63-7. PubMed ID: 2927580 [Abstract] [Full Text] [Related]
28. Inhibitory effect of a selective kappa receptor agonist, U-50, 488H, on methamphetamine-elicited ipsilateral circling behavior in rats with unilateral nigral lesions. Ohno M, Yamamoto T, Ueki S. Psychopharmacology (Berl); 1989 Jan 17; 97(2):219-21. PubMed ID: 2543013 [Abstract] [Full Text] [Related]
36. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord. Bhargava HN, Gulati A, Ramarao P. J Pharmacol Exp Ther; 1989 Oct 17; 251(1):21-6. PubMed ID: 2552075 [Abstract] [Full Text] [Related]
38. Feeding induced by opioid stimulation of the ventral striatum: role of opiate receptor subtypes. Bakshi VP, Kelley AE. J Pharmacol Exp Ther; 1993 Jun 17; 265(3):1253-60. PubMed ID: 8389860 [Abstract] [Full Text] [Related]
39. FMRFamide suppresses kappa opiate induced feeding in the mouse. Kavaliers M, Hirst M. Peptides; 1985 Jun 17; 6(5):847-9. PubMed ID: 3001666 [Abstract] [Full Text] [Related]
40. Evaluation of the interaction of mu and kappa opioid agonists on locomotor behavior in the horse. Mama KR, Pascoe PJ, Steffey EP. Can J Vet Res; 1993 Apr 17; 57(2):106-9. PubMed ID: 8490803 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]